| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2019-11-22 |
详情>>
内部人交易：
STONEPINE CAPITAL, L.P.股份增加89845.00股
|
| 2019-10-03 |
股东大会：
将于2019-11-05召开股东大会
会议内容 ▼▲
- 1.To approve as a special resolution: (i) the voluntary liquidation and dissolution of the Company pursuant to the Business Corporations Act (British Columbia) (the "BCBCA") at a time to be determined by the board of directors of the Company (the "Board"); (ii) the plan of liquidation and distribution substantially in the form attached to the accompanying Proxy Statement as Schedule A (the "Liquidation Plan"); and (iii) one or more distributions to shareholders of any remaining property of the Company under the voluntary liquidation and dissolution each as more particularly described in the accompanying Proxy Statement (together, the "Liquidation Resolution").
2.To approve as an ordinary resolution: (i) the appointment of Alvarez & Marsal Canada Inc. as the liquidator of the Company pursuant to Section 319(2)(a) of the BCBCA (the "Liquidator"); and (ii) the authorization of the Board to set the remuneration of the Liquidator (the "Liquidator Resolution").
3.To elect three directors to hold office until the next annual general meeting of shareholders of Novelion and until their successors are duly elected and qualified, subject to their earlier resignation or removal, or earlier in accordance with the Liquidation Plan (the "Election of Directors Proposal").
4.To approve on a non-binding, advisory basis the compensation of our named executive officers (the "Advisory Compensation Proposal").
5.To appoint Deloitte & Touche LLP as the independent registered public accounting firm of Novelion for the fiscal year ending December 31, 2019 and authorizing the Board to fix their remuneration (the "Appointment of Independent Auditors Proposal").
6.To transact such other business as may properly come before the Annual Meeting, or at any adjournments or postponements thereof.
7.To receive the Annual Report on Form 10-K, and the Audited Consolidated Financial Statements of Novelion for the year ended December 31, 2018, together with the Report of the Independent Registered Public Accounting Firm on those Financial Statements.
|
| 2019-10-03 |
详情>>
股本变动：
变动后总股本1961.89万股
|
| 2019-05-07 |
详情>>
业绩披露：
2019年一季报每股收益-1.67美元,归母净利润-3184.7万美元,同比去年增长2.99%
|
| 2019-03-15 |
详情>>
业绩披露：
2018年年报每股收益-5.76美元,归母净利润-1.08亿美元,同比去年增长14.51%
|
| 2018-11-13 |
详情>>
业绩披露：
2018年三季报(累计)每股收益-4.71美元,归母净利润-8889.8万美元,同比去年增长12.97%
|
| 2018-11-09 |
复牌提示：
2018-11-08 14:23:06 停牌，复牌日期 2018-11-08 14:28:06
|
| 2018-08-07 |
详情>>
业绩披露：
2018年中报每股收益-3.42美元,归母净利润-6409万美元,同比去年增长-22.31%
|
| 2018-07-11 |
股东大会：
将于2018-08-09召开股东大会
会议内容 ▼▲
- 1.To receive the Annual Report on Form 10-K (as amended), and the Audited Consolidated Financial Statements of Novelion for the year ended December 31, 2017, together with the Report of the Independent Registered Public Accounting Firm on those Financial Statements.
2.To elect eight directors (the “Directors”) to hold office until the 2019 annual meeting of stockholders and until their successors are duly elected and qualified, subject to their earlier resignation or removal.
3.To ratify the appointment of Deloitte & Touche LLP as independent registered public accounting firm of Novelion for the fiscal year ending December 31, 2018.
4.To conduct an advisory (non-binding) vote to approve the compensation of our named executive officers (“NEOs or “Named Executive Officers”).
5.To adopt and approve the proposed amendment and restatement of the Novelion 2017 Employee Stock Purchase Plan (as amended from time to time, the “ESPP”) to increase the number of common shares authorized for issuance under the ESPP.
6.To transact such other business as may properly come before the Annual Meeting, or at any adjournments or postponements thereof.
|
| 2018-05-10 |
详情>>
业绩披露：
2018年一季报每股收益-1.76美元,归母净利润-3282.8万美元,同比去年增长-6.03%
|
| 2018-03-16 |
详情>>
业绩披露：
2017年年报每股收益-6.81美元,归母净利润-1.27亿美元,同比去年增长-139.66%
|
| 2017-11-09 |
详情>>
业绩披露：
2017年三季报(累计)每股收益-5.49美元,归母净利润-1.02亿美元,同比去年增长-209.99%
|
| 2017-08-08 |
财报披露：
美东时间 2017-08-08 盘前发布财报
|
| 2017-08-08 |
详情>>
业绩披露：
2017年中报每股收益-2.82美元,归母净利润-5239.8万美元,同比去年增长-93.97%
|
| 2017-05-09 |
详情>>
业绩披露：
2017年一季报每股收益-1.67美元,归母净利润-3096.2万美元,同比去年增长-41.42%
|
| 2017-05-01 |
股东大会：
将于2017-06-28召开股东大会
会议内容 ▼▲
- 1. the election of nine directors for the ensuing year;
2. the appointment of Deloitte & Touche LLP as independent auditors of Novelion for the ensuing year and the authorization of the Audit Committee of the Board of Directors to fix the remuneration to be paid to the auditors;
3. an advisory (non-binding) vote to approve the compensation of our named executive officers;
4. an advisory (non-binding) vote on the frequency of the advisory vote to approve the compensation of our named executive officers;
5. the approval of the adoption of the 2017 Plan;
6. the approval of the adoption of the ESPP.
|
| 2017-03-30 |
详情>>
业绩披露：
2016年年报每股收益-4.69美元,归母净利润-5287万美元,同比去年增长-129.78%
|
| 2016-12-05 |
详情>>
拆分方案：
每5.0000合并分成1.0000股
|
| 2016-05-19 |
股东大会：
将于2016-06-17召开股东大会
会议内容 ▼▲
- 1.To receive the Annual Report on Form 10-K, and the Audited Consolidated Financial Statements of QLT for the year ended December 31, 2015, together with the Report of the Independent Registered Chartered Accountants on those Financial Statements.
2.To elect six directors (the "Directors") to serve for the ensuing year.
3.To approve the appointment of Deloitte LLP (formerly Deloitte & Touche LLP) as independent auditors of QLT for the ensuing year and to authorize the Directors to fix the remuneration to be paid to the auditors.
4.To conduct an advisory vote to approve the compensation of our named executive officers.
5.To transact such other business as may properly come before the Annual Meeting, or at any adjournments or postponements thereof.
|
| 2016-02-22 |
股东大会：
将于2016-03-18召开股东大会
会议内容 ▼▲
- 1.To approve a reorganization of QLT's share capital pursuant to a statutory plan of arrangement under Section 288 of the Business Corporations Act (British Columbia).
2.To transact such other business as may properly come before the Special Meeting, or at any adjournments or postponements thereof.
|
| 2015-12-09 |
股东大会：
将于2016-01-08召开股东大会
会议内容 ▼▲
- 1.To receive the Annual Report on Form 10-K, and the Audited Consolidated Financial Statements of QLT for the year ended December 31, 2014, together with the Report of the Independent Registered Chartered Accountants on those Financial Statements.
2.To elect six directors (the "Directors") to serve for the ensuing year.
3.To approve the appointment of Deloitte LLP (formerly Deloitte & Touche LLP) as independent auditors of QLT for the ensuing year and to authorize the Directors to fix the remuneration to be paid to the auditors.
4.To conduct an advisory vote on the compensation of our named executive officers.
5.To transact such other business as may properly come before the Annual Meeting, or at any adjournments or postponements thereof.
|
| 2014-11-19 |
股东大会：
将于2014-12-15召开股东大会
会议内容 ▼▲
- 1.To receive the Annual Report on Form 10-K, and the Audited Consolidated Financial Statements of QLT for the year ended December 31, 2013, together with the Report of the Independent Registered Chartered Accountants on those Financial Statements;
2.To elect six directors (the "Directors") to serve for the ensuing year;
3.To ratify and approve QLT's Amended and Restated Advance Notice Policy;
4.To approve the appointment of Deloitte LLP (formerly Deloitte & Touche LLP) as independent auditors of QLT for the ensuing year and to authorize the Directors to fix the remuneration to be paid to the auditors;
5.To conduct an advisory vote on the compensation of our named executive officers;
6.To transact such other business as may properly come before the Annual Meeting, or at any adjournments or postponements thereof.
|
| 2013-06-18 |
除权日：
美东时间 2013-06-28 每股派息3.92美元
|
| 2013-05-22 |
股东大会：
将于2013-06-14召开股东大会
会议内容 ▼▲
- 1. To receive the Annual Report on Form 10-K, and the Audited Consolidated Financial Statements of QLT for the year ended December 31, 2012, together with the Report of the Independent Registered Chartered Accountants on those Financial Statements;
2. To elect seven directors (the “Directors”) to serve for the ensuing year;
3. To approve a reduction of the capital of QLT’s common shares in the amount of US$200 million and a resulting special cash distribution to holders of QLT’s common shares;
4. To approve the appointment of Deloitte LLP (formerly Deloitte & Touche LLP) as independent auditors of QLT for the ensuing year and to authorize the Directors to fix the remuneration to be paid to the auditors;
5. To conduct an advisory vote on the compensation of our named executive officers;
6. To approve the amended and restated QLT 2000 Incentive Stock Plan;
7. To transact such other business as may properly come before the Annual Meeting, or at any adjournments or postponements thereof.
|